Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABBV compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 501d
Method
›
Moved together
ABBV
with
BMY
×0.43
co-movement · BMY on ABBV · 501d
r 0.41
scale to r 0.75
Shared co-movers
8
with ABBV
with BMY
AMGN
Amgen Inc
r 0.52
r 0.52
MRK
Merck & Co., Inc.
r 0.51
r 0.49
NVS
Novartis AG
r 0.48
r 0.49
PFE
Pfizer Inc
r 0.48
r 0.58
JNJ
Johnson & Johnson
r 0.45
r 0.43
BIIB
Biogen Inc.
r 0.43
r 0.45
ABBV, solid
BMY, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ABBV
AbbVie Inc.
Change
288.78
· pre 286.65
· delayed
Mkt cap
$521.1B
Revenue
$17.0B
Q2 FY26
Revenue
$61.2B
FY25
BMY
Bristol Myers Squibb Co
Change
63.03
· pre 62.63
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$128.8B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
288.78
pre 286.65
delayed
Price
63.03
pre 62.63
delayed
$521.1B
Mkt cap
$128.8B
Q2 FY26
$17.0B
Revenue
$13.1B
Q3 FY26
FY25
$61.2B
Revenue
$48.2B
FY25
Change
Change
ABBV
288.78
vs
BMY
63.03
Pre-market
Nov 3 '26
delayed